J&J, Janssen Face Risperdal Suit From Cherokee Nation
By Jody Godoy ( July 29, 2015, 2:08 PM EDT) -- Johnson & Johnson Inc. and subsidiary Janssen Pharmaceuticals Inc. removed a suit to Oklahoma federal court in which the Cherokee Nation claims that the companies misbranded its anti-psychotic Risperdal and failed to disclose the drug's risk to the elderly....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.